Your browser doesn't support javascript.
loading
Multicenter phase II study of FOLFIRI plus bevacizumab after discontinuation of oxaliplatin-based regimen for advanced or recurrent colorectal cancer (CR0802).
Suenaga, Mitsukuni; Nishina, Tomohiro; Mizunuma, Nobuyuki; Yasui, Hisateru; Ura, Takashi; Denda, Tadamichi; Ikeda, Junichi; Esaki, Taito; Nishisaki, Hogara; Takano, Yoshinao; Sugiyama, Yasuyuki; Muro, Kei.
Afiliação
  • Suenaga M; Cancer Institute Hospital of the Japanese Foundation for Cancer Research, 3-8-31, Ariake, Koto-ku, Tokyo, 135-8550, Japan. m.suenaga@jfcr.or.jp.
  • Nishina T; National Hospital Organization Shikoku Cancer Center, Kou 160 Minamiumemotomachi, Matsuyama, Ehime, 791-0280, Japan. tnishina@shikoku-cc.go.jp.
  • Mizunuma N; Cancer Institute Hospital of the Japanese Foundation for Cancer Research, 3-8-31, Ariake, Koto-ku, Tokyo, 135-8550, Japan. mizunuma@jfcr.or.jp.
  • Yasui H; National Hospital Organization Kyoto Medical Center, 1-1, Mukaihata-cho, Fukakusa, Fushimi-ku, Kyoto-shi, Kyoto, 612-8555, Japan. yasui-kyt@umin.ac.jp.
  • Ura T; Aichi Cancer Center Hospital, 1-1, Kanokoden, Chikusa-ku, Nagoya, 464-8681, Japan. tura@aichi-cc.jp.
  • Denda T; Chiba Cancer Center, 666-2, Nitona-cho, Chuo-ku, Chiba, 260-0801, Japan. tdenda@chiba-cc.jp.
  • Ikeda J; Japanese Red Cross Kitami Hospital, North-6, East-2, Kitami, Hokkaido, 090-0026, Japan. j_ikeda@kitami.jrc.or.jp.
  • Esaki T; National Kyushu Cancer Center, 3-1-1, Notame, Minami-ku, Fukuoka, 811-1395, Japan. tesaki@nk-cc.go.jp.
  • Nishisaki H; Hyogo Cancer Center, 13-70, Kitaouji-chou, Akashi, Hyogo, 672-8558, Japan. honssk-d@sanynet.ne.jp.
  • Takano Y; Southern Tohoku General Hospital, 7-115, Yatsuyamada, Koriyama, Fukushima, 963-8563, Japan. ytakano36@gmail.com.
  • Sugiyama Y; Teikyo University School of Medicine University Hospital, Mizonokuchi, 3-8-3, Mizonokuchi, Takatsu-ku, Kawasaki, Kanagawa, 213-8507, Japan. ysugi@gmhosp.gifu.gifu.jp.
  • Muro K; Aichi Cancer Center Hospital, 1-1, Kanokoden, Chikusa-ku, Nagoya, 464-8681, Japan. kmuro@aichi-cc.jp.
BMC Cancer ; 15: 176, 2015 Mar 25.
Article em En | MEDLINE | ID: mdl-25884814
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Camptotecina / Neoplasias Colorretais / Protocolos de Quimioterapia Combinada Antineoplásica / Bevacizumab / Recidiva Local de Neoplasia Tipo de estudo: Clinical_trials Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: BMC Cancer Assunto da revista: NEOPLASIAS Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Japão
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Camptotecina / Neoplasias Colorretais / Protocolos de Quimioterapia Combinada Antineoplásica / Bevacizumab / Recidiva Local de Neoplasia Tipo de estudo: Clinical_trials Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: BMC Cancer Assunto da revista: NEOPLASIAS Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Japão